BALDO LANCE 4
4 · Adaptive Biotechnologies Corp · Filed Mar 8, 2021
Insider Transaction Report
Form 4
BALDO LANCE
Chief Medical Officer
Transactions
- Award
Common Stock
2021-03-04+22,894→ 22,894 total - Award
Stock Option (Right to Buy)
2021-03-04+57,234→ 57,234 totalExercise: $43.68Exp: 2021-03-04→ Common Stock (57,234 underlying)
Footnotes (1)
- [F1]The options vest with respect to 1/4 of such shares on March 4, 2022, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.